The study, conducted by Elissa Ozanne, PhD, at Dartmouth found that 11 of the 15 women, aged 45-79 years, interviewed before and after using the mHealth tool preferred it to a paper tool and found it easy to use.
Interviewing women at a breast-imaging center in an urban safety net institution before and after they used a "mHealth" mobile health app on a tablet, Elissa Ozanne, PhD, from Dartmouth's Norris Cotton Cancer Center and colleagues concluded that older, diverse, and low income women found it easy to use and acceptable. Published in the Journal of Health Disparities Research Practices, the paper with these findings is "Can mHealth Improve Risk Assessment in Underserved Populations? Acceptability of a Breast Health Questionnaire App in Ethnically Diverse, Older, Low-Income Women."
"Studies such as this are critical to understand how mHealth tools can be used effectively in diverse, low-income populations," said Ozanne. "We need to design all tools, and particularly novel tools such as mHealth tools, with these populations in mind in order to ensure equitable access. This study identifies some of the barriers and benefits of using an mHealth tool in this low-income, diverse population."
Link to the news release by Dartmouth: http://bit.ly/1x8u2Fv
More Accurate Detection of Self-Injurious Behavior Needed for Minoritized Youth
October 29th 2024A recent retrospective, cross-sectional study found that detecting self-injurious thoughts and behaviors in youth requires improvement to ensure equitable identification of at-risk patients.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
October 21st 2024Examining care transitions in hospitalized patients revealed lower diagnostic error rates compared with traditional methods, highlighting the effectiveness of this approach in identifying diagnostic challenges.
Read More